Wells Fargo’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29
| Closed | -$682 | – | 7512 |
|
|
2024
Q1 | $682 | Sell |
29
-1
| -3% | -$13 | ﹤0.01% | 6231 |
|
|
2023
Q4 | $346 | Sell |
30
-6
| -17% | -$84 | ﹤0.01% | 6468 |
|
|
2023
Q3 | $692 | Buy |
36
+5
| +16% | +$122 | ﹤0.01% | 6290 |
|
|
2023
Q2 | $909 | Hold |
31
| – | – | ﹤0.01% | 6339 |
|
|
2023
Q1 | $986 | Buy |
31
+1
| +3% | +$34 | ﹤0.01% | 6386 |
|
|
2022
Q4 | $806 | Sell |
30
-25
| -45% | -$827 | ﹤0.01% | 6257 |
|
|
2022
Q3 | $2K | Buy |
55
+25
| +83% | +$984 | ﹤0.01% | 6207 |
|
|
2022
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 6630 |
|
|
2022
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 6876 |
|
|
2021
Q4 | $1K | Sell |
30
-24
| -44% | -$1.29K | ﹤0.01% | 7088 |
|
|
2021
Q3 | $3K | Buy |
54
+1
| +2% | +$75 | ﹤0.01% | 6511 |
|
|
2021
Q2 | $5K | Sell |
53
-214
| -80% | -$21.7K | ﹤0.01% | 6358 |
|
|
2021
Q1 | $30K | Sell |
267
-285
| -52% | -$28K | ﹤0.01% | 6035 |
|
|
2020
Q4 | $41K | Sell |
552
-1,707
| -76% | -$131K | ﹤0.01% | 5659 |
|
|
2020
Q3 | $159K | Buy |
2,259
+2,123
| +1,561% | +$187K | ﹤0.01% | 5079 |
|
|
2020
Q2 | $12K | Buy |
136
+124
| +1,033% | +$12.2K | ﹤0.01% | 5819 |
|
|
2020
Q1 | $1K | Buy |
12
+1
| +9% | +$96 | ﹤0.01% | 6093 |
|
|
2019
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 6281 |
|
|
2019
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 6305 |
|
|
2019
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 6295 |
|
|
2019
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 5973 |
|
|
2018
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 6320 |
|
|
2018
Q3 | $0 | Hold |
11
| – | – | ﹤0.01% | 6596 |
|
|
2018
Q2 | $1K | Sell |
11
-28
| -72% | -$2.07K | ﹤0.01% | 6269 |
|
|
2018
Q1 | $6K | Buy |
39
+1
| +3% | +$245 | ﹤0.01% | 6037 |
|
|
2017
Q4 | $9K | Buy |
38
+6
| +19% | +$1.34K | ﹤0.01% | 5953 |
|
|
2017
Q3 | $7K | Buy |
32
+12
| +60% | +$2.39K | ﹤0.01% | 5955 |
|
|
2017
Q2 | $4K | Hold |
20
| – | – | ﹤0.01% | 5970 |
|
|
2017
Q1 | $5K | Buy |
+20
| New | +$4.56K | ﹤0.01% | 6037 |
|
|
2016
Q2 | – | Sell |
-16
| Closed | -$3K | – | 6358 |
|
|
2016
Q1 | $3K | Buy |
+16
| New | +$3.98K | ﹤0.01% | 5975 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$281 | – | 6442 |
|
|
2015
Q3 | $0 | Buy |
+1
| New | +$348 | ﹤0.01% | 6478 |
|
Other funds holding VTVT
SB
BBA
PCMC
SFCL
Wells Fargo's VTVT Position: Q2 2024 in Review
Wells Fargo sold out of vTv Therapeutics (VTVT) in Q2 2024, closing a stake of 29 shares — an estimated $682 sold.
Wells Fargo first reported a position in VTVT in Q3 2015 and held it in 31 quarters. The position peaked at $159K in Q3 2020. 19 funds tracked by Wall St. Rank hold VTVT as of Q2 2024.
- Wells Fargo reported no remaining vTv Therapeutics position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 29 vTv Therapeutics shares in Q2 2024, an estimated $682.
- Wells Fargo first reported a position in vTv Therapeutics in Q3 2015 and held it in 31 quarters.
- Wells Fargo's vTv Therapeutics position peaked at $159K in Q3 2020.
- 19 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.